Top 3 abstracts concerning hormone-receptor-positive early breast cancer Post San Antonio 2020 Update

Simon Peter Gampenrieder; Gabriel Rinnerthaler; Richard Greil

doi:10.1007/s12254-021-00726-0

Top 3 abstracts concerning hormone-receptor-positive early breast cancer Post San Antonio 2020 Update

Simon Peter Gampenrieder (First author), Gabriel Rinnerthaler (Co-author), Richard Greil^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Review article › peer-review

1 Citation (Web of Science)

Original language	English
Journal	memo - Magazine of European Medical Oncology
DOIs	https://doi.org/10.1007/s12254-021-00726-0
Publication status	Published - 2021

Keywords

ENDOCRINE THERAPY
PALBOCICLIB
VALIDATION
RISK

Access to Document

10.1007/s12254-021-00726-0

Cite this

@article{251fa5da585c4257bd34381295233254,

title = "Top 3 abstracts concerning hormone-receptor-positive early breast cancer Post San Antonio 2020 Update",

keywords = "ENDOCRINE THERAPY, PALBOCICLIB, VALIDATION, RISK",

author = "Gampenrieder, \{Simon Peter\} and Gabriel Rinnerthaler and Richard Greil",

note = "all: IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, M{\"u}llner Hauptstra{\ss}e 48, 5020, Salzburg, Austria",

year = "2021",

doi = "10.1007/s12254-021-00726-0",

language = "English",

journal = "memo - Magazine of European Medical Oncology",

issn = "1865-5041",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Top 3 abstracts concerning hormone-receptor-positive early breast cancer Post San Antonio 2020 Update

AU - Gampenrieder, Simon Peter

AU - Rinnerthaler, Gabriel

AU - Greil, Richard

N1 - all: IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - ENDOCRINE THERAPY

KW - PALBOCICLIB

KW - VALIDATION

KW - RISK

U2 - 10.1007/s12254-021-00726-0

DO - 10.1007/s12254-021-00726-0

M3 - Review article

SN - 1865-5041

JO - memo - Magazine of European Medical Oncology

JF - memo - Magazine of European Medical Oncology

ER -